ATHX Balance Sheets
(Annual, GAAP in millions $) |
(Dec 31 2022) 2022 |
(Dec 31 2021) 2021 |
(Dec 31 2020) 2020 |
(Dec 31 2019) 2019 |
(Dec 31 2017) 2017 |
ASSETS |
Cash & cash equivalent |
9.04 |
37.41 |
51.55 |
35.00 |
29.32 |
Cash, Cash Eqvivalents Other |
- |
- |
- |
- |
- |
Cash
& Short-term Investments |
9.04 |
37.41 |
51.55 |
35.00 |
29.32 |
Accounts receivable |
0.72 |
1.41 |
0.09 |
0.02 |
0.74 |
Unbilled Receivables, Current RE |
- |
3.00 |
- |
- |
- |
Notes Receivable, Current |
- |
- |
- |
- |
- |
Prepaid Clinical Trial Costs |
2.75 |
- |
- |
- |
- |
Operating Lease Right Of Use Asset |
7.85 |
8.96 |
- |
- |
- |
Inventories |
- |
- |
- |
- |
- |
Other Current Assets |
2.75 |
- |
- |
0.99 |
0.00 |
Prepaid Expense And Other Assets Current |
1.03 |
4.21 |
2.93 |
1.17 |
1.14 |
Total Current Assets |
13.54 |
46.03 |
54.56 |
37.17 |
31.19 |
Equipment/Property/Plant Net |
4.21 |
3.69 |
3.16 |
2.88 |
2.21 |
Goodwill net |
- |
- |
- |
- |
- |
Intangible Assets |
- |
- |
- |
- |
- |
Long-term investments |
- |
- |
- |
- |
- |
Accounts Receivable, Net, Noncurrent |
- |
- |
- |
- |
- |
Financial Instruments |
- |
- |
- |
- |
- |
Deferred Tax Assets, Net of Valuation Allowance, Liabilities |
- |
- |
- |
- |
- |
Other Assets, Noncurrent |
8.00 |
10.00 |
- |
- |
0.20 |
Deferred, Prepaid and Other Assets, Noncurrent |
- |
- |
- |
- |
- |
Discontinued operations, Noncurrent |
- |
- |
- |
- |
- |
Deposits And Other Assets Non Current |
2.14 |
1.51 |
2.00 |
1.61 |
- |
Total Assets |
27.73 |
60.18 |
59.71 |
41.67 |
33.59 |
LIABILITIES |
Accounts Payable, Current AC |
27.77 |
1.12 |
11.34 |
9.05 |
4.47 |
Employee-related Liabilities, Current AC |
2.17 |
4.84 |
2.98 |
1.50 |
1.49 |
Financial Instruments |
- |
- |
- |
- |
- |
Notes Payable, Current NO |
- |
- |
- |
- |
- |
Other Liabilities, Current |
8.51 |
23.91 |
8.64 |
2.29 |
3.35 |
Taxes Payable |
- |
- |
- |
- |
- |
Deferred Revenue, Current DE |
- |
- |
- |
- |
0.77 |
Discontinued Operation, Liabilities, Current |
- |
- |
- |
- |
- |
Deferred Accounts Payable Current |
7.23 |
3.77 |
6.87 |
- |
- |
Operating Lease Liability Current |
- |
- |
- |
- |
- |
Accrued Clinical Trial Related Costs Current |
- |
- |
- |
- |
- |
Accrued Liabilities And Other Liabilities Current |
- |
- |
- |
- |
- |
Operating Lease Liability Noncurrent |
7.94 |
- |
- |
- |
- |
Total Current Liabilities |
38.44 |
29.86 |
22.95 |
12.84 |
10.08 |
Long-term debt |
- |
- |
- |
- |
- |
Capital Lease and Other |
- |
- |
- |
- |
- |
Long-term Debt Convertible |
- |
- |
- |
- |
- |
Total
Long-term Debt |
- |
- |
- |
- |
- |
Financial Instruments, Insurance, Noncurrent |
- |
- |
- |
- |
- |
Employee Benefit Plans, Noncurrent |
- |
- |
- |
- |
- |
Customer Advances, Noncurrent CU |
- |
- |
- |
- |
0.13 |
Accrued Income Taxes, Noncurrent |
- |
- |
- |
- |
- |
Discontinued Operation, Liabilities, Noncurrent |
- |
- |
- |
- |
- |
Accounts Payable, Related Parties, Noncurrent |
- |
13.95 |
5.40 |
5.56 |
0.00 |
Total Liabilities |
38.44 |
43.82 |
28.35 |
18.40 |
10.22 |
SHAREHOLDER'S EQUITY |
Common Stock Value |
0.02 |
0.24 |
0.20 |
0.16 |
0.12 |
Additional Paid In Capital Common Stock |
632.01 |
599.47 |
527.55 |
440.74 |
373.88 |
Retained Earnings / Accumulated Deficit |
-655.88 |
-583.34 |
-496.39 |
-417.62 |
-350.63 |
Other Equity |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Noncontrolling interests & other |
- |
- |
- |
- |
- |
Total
Stockholder's Equity |
-23.85 |
16.37 |
31.36 |
23.27 |
23.38 |
Liabilities & Stockholder's
Equity |
27.73 |
60.18 |
59.71 |
41.67 |
33.59 |